CoChat

The DOI matches its Crossref record; 136 of the 136 references it cites were found in a registry or an index.

Overcoming the Host Immune Response to Adeno-Associated Virus Gene Delivery Vectors: The Race Between Clearance, Tolerance, Neutralization, and Escape

Open access
Mingozzi, Federico, High, Katherine A. · 2017 · Annual Review of Virology

Abstract

Immune responses in gene therapy with adeno-associated virus (AAV) vectors have been the object of almost two decades of study. Although preclinical models helped to define and predict certain aspects of interactions between the vector and the host immune system, most of our current knowledge has come from clinical trials. These studies have allowed development of effective interventions for modulating immunotoxicities associated with vector administration, resulting in therapeutic advances. However, the road to full understanding and effective modulation of immune responses in gene therapy is still long; the determinants of the balance between tolerance and immunogenicity in AAV vector–mediated gene transfer are not fully understood, and effective solutions for overcoming preexisting neutralizing antibodies are still lacking. However, despite these challenges, the goal of reliably delivering effective gene-based treatments is now in sight.

Overview

Integrity signals

Registry

Crossref · 10.1146/annurev-virology-101416-041936

Cites

136 of 136 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 136 references

Research works printed but not linked: 5

  1. Medawar PB, 1948, Br. J. Exp. Pathol., 29, 58
  2. Lüth S, 2008, J. Clin. Investig., 118, 3403
  3. Miesbach W, 2016, Haemophilia, 22, 151
  4. 132. Dimension Ther. 2017. Dimension announces interim topline results from ongoing phase 1/2 clinical program for DTX101, Dimension's lead AAV product candidate in development for adult patients with moderate/severe to severe hemophilia B. Press Release, Jan. 31.http://investors.dimensiontx.com/phoenix.zhtml?c=254192&p=irol-newsArticle&ID=2240877
  5. Pasi J, 2016, Haemophilia, 22, 151

Cited by

See all 210

Metadata

Authors
Mingozzi, F., & High, K. A.
Affiliations
  • Inserm (FR)
  • Spark Therapeutics (United States) (US)
Venue
Annual Review of Virology
Published
2017-09-29
Volume
4
Issue
1
Pages
511-534
ISSN
  • 2327-056X (ISSN-L)
  • 2327-0578
OpenAlex
W2603828830
Cited by
206
References
136
Citations by year
2026: 16 · 2025: 25 · 2024: 17 · 2023: 19 · 2022: 21 · 2021: 26 · 2020: 36 · 2019: 22 · 2018: 19 · 2017: 5
FWCI
2.89
Type
journal article
Language
en
Open access
Locations
  • Annual Review of Virology (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
Funders
FP7 Ideas: European Research Council (617432)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Keywords
adeno-associated virus vectors, gene therapy, host immune response, immunogenicity, immune tolerance, neutralizing antibodies, immune evasion, immunomodulation, AAV serotypes
MeSH terms
Dependovirus, Animals, Genetic Vectors, Humans, Immune Tolerance, Immunity, Active, Genetic Therapy, Gene Transfer Techniques, Mice, Antibodies, Neutralizing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Overcoming the Host Immune Response to Adeno-Associated Virus Gene Delivery Vectors: The Race Between Clearance, Tolerance, Neutralization, and Escape. https://app.cochat.ai/papers/10.1146/annurev-virology-101416-041936
The paper
Mingozzi, F., & High, K. A. (2017). Overcoming the Host Immune Response to Adeno-Associated Virus Gene Delivery Vectors: The Race Between Clearance, Tolerance, Neutralization, and Escape. Annual Review of Virology. https://doi.org/10.1146/annurev-virology-101416-041936

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.